Search Results - "FREEMAN, Scott N"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    RhoBTB2 (DBC2) Is a Mitotic E2F1 Target Gene with a Novel Role in Apoptosis by Freeman, Scott N., Ma, Yihong, Cress, W. Douglas

    Published in The Journal of biological chemistry (25-01-2008)
    “…We have identified the RhoBTB2 putative tumor suppressor gene as a direct target of the E2F1 transcription factor. Overexpression of E2F1 led to up-regulation…”
    Get full text
    Journal Article
  2. 2

    RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor by Freeman, Scott N., Cress, W. Douglas

    Published in Cancer biology & therapy (01-12-2010)
    “…Commentary to: Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells Li-Jun Ling, Chao Lu, Guo-Ping Zhou and Shui Wang…”
    Get full text
    Journal Article
  3. 3

    E2F4 deficiency promotes drug-induced apoptosis by Ma, Yihong, Freeman, Scott N., Cress, W. Douglas

    Published in Cancer biology & therapy (01-12-2004)
    “…E2F1 and E2F4 are known to have opposing roles in cell cycle control. In the present work, we examine the role of both E2F1 and E2F4 in apoptosis induced by…”
    Get full text
    Journal Article
  4. 4

    What the Orphan Drug Act Has Done Lately for Children With Rare Diseases: A 10-Year Analysis by THORAT, Chandana, KUI XU, FREEMAN, Scott N, BONNEL, Renan A, JOSEPH, Francesca, IAN PHILLIPS, M, IMOISILI, Menfo A

    Published in Pediatrics (Evanston) (01-03-2012)
    “…The 1983 US Orphan Drug Act (ODA) provided incentives to stimulate treatment product development for patients with rare disease. This article highlights a…”
    Get full text
    Journal Article
  5. 5

    The Orphan Drug Act and the Development of Stem Cell-Based Products for Rare Diseases by Freeman, Scott N., Burke, Kathryn A., Imoisili, Menfo A., Coté, Timothy R.

    Published in Cell stem cell (03-09-2010)
    “…The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many conditions that stand to benefit from stem cell-based…”
    Get full text
    Journal Article
  6. 6

    Re: Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia by Freeman, Scott N., Bepler, Gerold, Haura, Eric, Sutphen, Rebecca, Cress, W. Douglas

    “…MCL-1 promoter insertion * All patients Wt Wt/Mut Mut/Mut Parameters and events (n = 134) (n = 107) (n = 8) (n = 19) P Parameter Sex Male 79 (59%) 62 (46%) 6…”
    Get full text
    Journal Article
  7. 7

    Filtration processes— A distinguished history and a promising future by Logsdon, Gary S., Horsley, Michael B., Freeman, Scott D.N., Neemann, Jeff J., Budd, George C.

    Published in Journal - American Water Works Association (01-03-2006)
    “…This article chronicles advances in the filtration of public drinking water supplies from the late 1800s to today and discusses the future of filtration…”
    Get full text
    Journal Article
  8. 8

    Analysis of E2F1 target genes involved in cell cycle and apoptosis by Freeman, Scott N

    Published 01-01-2007
    “…One of the main results of Rb-E2F pathway disruption is deregulation of the E2F family of transcription factors, which can lead to inappropriate proliferation,…”
    Get full text
    Dissertation
  9. 9

    Silica fouling revisited by Freeman, Scott D.N., Majerle, Randall J.

    Published in Desalination (1995)
    “…The potential for silica scale formation in reverse osmosis (RO) systems is thought to limit recovery in many installations, which may unnecessarily increase…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Recent developments in membrane water reuse projects by Freeman, Scott D.N., Morin, O.J.

    Published in Desalination (1995)
    “…There is increasing interest in the use of membrane processing of wastewater for reuse as industrial process water, groundwater recharge, and irrigation…”
    Get full text
    Journal Article Conference Proceeding